News
08-02-2013, 03:40 AM
NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an Early Access Program for nCounter Elements™, a line of General Purpose Reagents (GPRs) developed specifically to meet the needs of translational research and clinical laboratories.
More... (http://www.news-medical.net/news/20130802/NanoString-announces-Early-Access-Program-for-nCounter-Elements-used-in-translational-research.aspx)
More... (http://www.news-medical.net/news/20130802/NanoString-announces-Early-Access-Program-for-nCounter-Elements-used-in-translational-research.aspx)